Request Deal Involvement
Amphastar Pharmaceuticals completed the acquisition of BAQSIMI from Eli Lilly for $1.1bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Wilson Sonsini Goodrich & Rosati
financial advisors
Jefferies & Company
debt providers
Wells Fargo Securities
debt providers
Capital One Financial Corporation
debt providers
JP Morgan
debt providers
Fifth Third Bancorp
debt providers
East West Bank
debt providers
Cathay Bank
debt providers
CIBC World Markets
legal advisors
Kirkland & Ellis
legal advisors
Covington & Burling
financial advisors
JP Morgan
or
Principals
target
BAQSIMI
bidder
AMPHASTAR PHARMACEUTICALS
vendor
ELI LILLY AND COMPANY
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite